MedTrace Logo

Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection

NCT01438333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-06-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate beneficial effects of probiotic Lactobacillus brevis CD2 tablets in addition to the primary treatment for patients with chronic periodontitis (Full Mouth Disinfection), at local level and at systemic level.

Conditions

  • Chronic Periodontitis

Interventions

DIETARY_SUPPLEMENT

lactobacillus brevis tablets

5 tablets a day for 6 weeks

DIETARY_SUPPLEMENT

PLACEBO

5 tablets a day for 6 weeks

Sponsors & Collaborators

  • University of L'Aquila

    lead OTHER

Principal Investigators

  • ENRICO MARCHETTI, DDS · University of L'Aquila

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438333 on ClinicalTrials.gov